Interconnect is here to help

Care Manager Team

When you start treatment with
LYNAVOY (linerixibat), you’re not alone

Interconnect provides a dedicated team of Care Managers who are here to support you every step of the way—from the moment your prescription is received through delivery and ongoing therapy.

Your Care Manager Team serves as your point of contact, helping to simplify the process and answer any logistical questions along the way.

Your Support Team
can help with:

  • Coordinating your prescription and shipment
  • Navigating insurance coverage and approvals
  • Providing updates on the status of your medication
  • Connecting you to additional support resources
  • Offering operational guidance throughout your LYNAVOY treatment journey

You are now leaving Interconnect

Any information you provide after you leave this site and enter another site will be subject to the other website’s privacy policy and terms and conditions. Interconnect is not responsible for the use, security, or disclosure of any information you may provide to another site.

The information on this site is intended for healthcare professionals in the United States, its territories, and Puerto Rico, and is not intended for the general public.

Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., has voluntarily withdrawn OCALIVA® (obeticholic acid) from the market for the treatment of primary biliary cholangitis (PBC), effective November 14.

Patients should talk to their healthcare professionals and may also contact Intercept's patient support services (Interconnect at 1-844-622-4278) through December 31, 2025.

Interconnect's website is being temporarily maintained and is no longer fully functional for enrollment purposes due to the withdrawal of OCALIVA.

Healthcare professionals can contact Medical Information at medinfo@interceptpharma.com or 1-844-782-4278. Additionally, patients or healthcare professionals may request Full Prescribing Information or the OCALIVA Medication Guide by contacting medinfo@interceptpharma.com.

For all other inquiries please contact: info@interceptpharma.com